Evidence map›Paper›PMID 38571752›Full record

ArticleFrontiers in nutrition2024

Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet.

Anouk Charlot, Anthony Bringolf, Joris Mallard, Anne-Laure Charles, Nathalie Niederhoffer, Delphine Duteil, Allan F Pagano, Bernard Geny, Joffrey Zoll

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Nutritional and Fasting Strategies for the Management of MASLD/MASH: An Integrative Review.JGH open : an open access journal of gastroenterology and hepatology · 2025
    Review
  4. Article
  5. Review
  6. The miRNomics of antiretroviral therapy-induced obesity.Functional & integrative genomics · 2025
    Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Anouk CharlotBiomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Anthony BringolfBiomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Joris MallardBiomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Anne-Laure CharlesBiomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Nathalie NiederhofferBiomedicine Research Center of Strasbourg (CRBS), UR7296, NeuroCardiovascular Pharmacology and Toxicology Laboratory (LPTNC), University of Strasbourg, Strasbourg, France.
Delphine DuteilUniversity of Strasbourg, CNRS, Inserm, IGBMC UMR 7104-UMR-S 1258, Illkirch, France.
Allan F PaganoBiomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Bernard GenyBiomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Joffrey ZollBiomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Université de Strasbourg · FRMitochondrie, stress oxydant et protection musculaire · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Obesity and metabolic complications, such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD), are one of the greatest public health challenges of the 21st century. The major role of high sugar and carbohydrate consumption rather than caloric intake in obesity and NAFLD pathophysiology remains a subject of debate. A low-carbohydrate but high-fat diet (LCHFD) has shown promising results in obesity management, but its effects in preventing NAFLD need to be detailed. This study aims to compare the effects of a LCHFD with a high-fat high-sugar obesogenic Western diet (WD) on the progression of obesity, type 2 diabetes, and nonalcoholic fatty liver disease. Methods: Male C57BL/6J mice were initially fed a WD for 10 weeks. Subsequently, they were either switched to a LCHFD or maintained on the WD for an additional 6 weeks. Hepatic effects of the diet were explored by histological staining and RT-qPCR. Results: After the initial 10 weeks WD feeding, LCHF diet demonstrated effectiveness in halting weight gain, maintaining a normal glucose tolerance and insulin levels, in comparison to the WD-fed mice, which developed obesity, glucose intolerance, increased insulin levels and induced NAFLD. In the liver, LCHFD mitigated the accumulation of hepatic triglycerides and the increase in Fasn relative gene expression compared to the WD mice. Beneficial effects of the LCHFD occurred despite a similar calorie intake compared to the WD mice. Conclusion: Our results emphasize the negative impact of a high sugar/carbohydrate and lipid association for obesity progression and NAFLD development. LCHFD has shown beneficial effects for NAFLD management, notably improving weight management, and maintaining a normal glucose tolerance and liver health.

Indexed as

insulinlow-carbohydrate dietnon-alcoholic fatty liver diseaseobesityWestern diet

Identifiers

PMID38571752
PMCPMC10987868
OpenAlexW4393011984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.